CellViT: Vision Transformers for precise cell segmentation and classification.

Journal: Medical image analysis
PMID:

Abstract

Nuclei detection and segmentation in hematoxylin and eosin-stained (H&E) tissue images are important clinical tasks and crucial for a wide range of applications. However, it is a challenging task due to nuclei variances in staining and size, overlapping boundaries, and nuclei clustering. While convolutional neural networks have been extensively used for this task, we explore the potential of Transformer-based networks in combination with large scale pre-training in this domain. Therefore, we introduce a new method for automated instance segmentation of cell nuclei in digitized tissue samples using a deep learning architecture based on Vision Transformer called CellViT. CellViT is trained and evaluated on the PanNuke dataset, which is one of the most challenging nuclei instance segmentation datasets, consisting of nearly 200,000 annotated nuclei into 5 clinically important classes in 19 tissue types. We demonstrate the superiority of large-scale in-domain and out-of-domain pre-trained Vision Transformers by leveraging the recently published Segment Anything Model and a ViT-encoder pre-trained on 104 million histological image patches - achieving state-of-the-art nuclei detection and instance segmentation performance on the PanNuke dataset with a mean panoptic quality of 0.50 and an F-detection score of 0.83. The code is publicly available at https://github.com/TIO-IKIM/CellViT.

Authors

  • Fabian Horst
    Department of Training and Movement Science, Institute of Sport Science, Johannes Gutenberg-University Mainz, Mainz, Rhineland-Palatinate, Germany.
  • Moritz Rempe
    Institute for AI in Medicine (IKIM), University Hospital Essen (AöR), 45131 Essen, Germany; Cancer Research Center Cologne Essen (CCCE), West German Cancer Center Essen, University Hospital Essen (AöR), 45147 Essen, Germany.
  • Lukas Heine
    Institute for AI in Medicine (IKIM), University Hospital Essen (AöR), 45131 Essen, Germany; Cancer Research Center Cologne Essen (CCCE), West German Cancer Center Essen, University Hospital Essen (AöR), 45147 Essen, Germany.
  • Constantin Seibold
    Institute for AI in Medicine (IKIM), University Hospital Essen (AöR), 45131 Essen, Germany; Clinic for Nuclear Medicine, University Hospital Essen (AöR), 45147 Essen, Germany.
  • Julius Keyl
    Institute of AI in Medicine (IKIM), University Hospital Essen, Girardetstraße 2, 45131, Essen, Germany.
  • Giulia Baldini
    Institute for Artificial Intelligence in Medicine, University Medicine Essen, Essen, Germany.
  • Selma Ugurel
    Department of Dermatology, University Hospital Essen (AöR), 45147 Essen, Germany; German Cancer Consortium (DKTK, Partner site Essen), 69120 Heidelberg, Germany.
  • Jens Siveke
    West German Cancer Center, University of Essen, Essen, Germany.
  • Barbara Grünwald
    Department of Urology, West German Cancer Center, 45147 University Hospital Essen (AöR), Germany; Princess Margaret Cancer Centre, M5G 2M9 Toronto, Ontario, Canada.
  • Jan Egger
    Institute for Computer Graphics and Vision, Faculty of Computer Science and Biomedical Engineering, Graz University of Technology, Graz, Austria.
  • Jens Kleesiek
    AG Computational Radiology, Abteilung Radiologie, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Deutschland. j.kleesiek@dkfz-heidelberg.de.